Azitromicin je polusintetički makrolidni antibiotik azalidne klase. Poput drugih makrolidnih antibiotika, azitromicin inhibira bakterijsku proteinsku sintezu vezivanjem za 50S ribozomalnu podjedinicu bakterijskog 70S ribozoma.[3][4][5]

Azitromicin
(IUPAC) ime
(2R,3S,4R,5R,8R,10R,11R,12S,13S,14R)-11[(2S,3R,4S,6R)-4-(dimetilamino)-3-hidroksi-6-metiloksan-2-il]oksi2-etil-3,4,10-trihidroksi-13[(2R,4R,5S,6S)-5-hidroksi-4-metoksi-4,6-dimetiloksan-2-il]oksi3,5,6,8,10,12,14-heptametil-1-oksa-6-azaciklopentadekan-15-on
Klinički podaci
Robne marke Azenil, Azibiot, Azifine, Azitromax
AHFS/Drugs.com Monografija
Identifikatori
CAS broj 83905-01-5
ATC kod J01FA10 , S01AA26
DrugBank DB00207
KEGG[1] C06838 DaY
ChEMBL[2] CHEMBL2955 DaY
Hemijski podaci
Formula C38H72N2O12 
Mol. masa 748.9845
SMILES eMolekuli & PubHem
Fizički podaci
Tačka topljenja 114 °C (237 °F)
Farmakokinetički podaci
Poluvreme eliminacije 68 sati
Izlučivanje Bilijarno, uglavnom nepromenjen lek
Farmakoinformacioni podaci
Trudnoća ?
Pravni status
Način primene Intravenozno; Oralno

Reference

uredi
  1. Joanne Wixon, Douglas Kell (2000). „Website Review: The Kyoto Encyclopedia of Genes and Genomes — KEGG”. Yeast 17 (1): 48–55. DOI:10.1002/(SICI)1097-0061(200004)17:1<48::AID-YEA2>3.0.CO;2-H. 
  2. Gaulton A, Bellis LJ, Bento AP, Chambers J, Davies M, Hersey A, Light Y, McGlinchey S, Michalovich D, Al-Lazikani B, Overington JP. (2012). „ChEMBL: a large-scale bioactivity database for drug discovery”. Nucleic Acids Res 40 (Database issue): D1100-7. DOI:10.1093/nar/gkr777. PMID 21948594.  edit
  3. Noedl H, Krudsood S, Chalermratana K, Silachamroon U, Leowattana W, Tangpukdee N, Looareesuwan S, Miller RS, Fukuda M, Jongsakul K, Sriwichai S, Rowan J, Bhattacharyya H, Ohrt C, Knirsch C: Azithromycin combination therapy with artesunate or quinine for the treatment of uncomplicated Plasmodium falciparum malaria in adults: a randomized, phase 2 clinical trial in Thailand. Clin Infect Dis. 2006 Nov 15;43(10):1264-71. Epub 2006 Oct 12. PMID 17051490
  4. Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS (2011). „DrugBank 3.0: a comprehensive resource for omics research on drugs”. Nucleic Acids Res. 39 (Database issue): D1035-41. PMID 21059682. 
  5. Wishart DS, Knox C, Guo AC, Cheng D, Shrivastava S, Tzur D, Gautam B, Hassanali M (2008). „DrugBank: a knowledgebase for drugs, drug actions and drug targets”. Nucleic Acids Res 36 (Database issue): D901-6. PMID 18048412. 

Spoljašnje veze

uredi